nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallium nitrate—TF—Differentiation Pathway—CNTF—glaucoma	0.0256	0.0587	CbGpPWpGaD
Gallium nitrate—IL1B—endothelium—glaucoma	0.0201	0.194	CbGeAlD
Gallium nitrate—IL1B—Interleukin-1 processing—IL1A—glaucoma	0.0145	0.0332	CbGpPWpGaD
Gallium nitrate—RRM2—Synthesis and interconversion of nucleotide di- and triphosphates—TXN—glaucoma	0.0139	0.032	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—eye—glaucoma	0.0135	0.13	CbGeAlD
Gallium nitrate—TF—Differentiation Pathway—NTF4—glaucoma	0.0134	0.0308	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—retina—glaucoma	0.0134	0.129	CbGeAlD
Gallium nitrate—Rales—Dorzolamide—glaucoma	0.0132	0.0286	CcSEcCtD
Gallium nitrate—BGLAP—connective tissue—glaucoma	0.0111	0.107	CbGeAlD
Gallium nitrate—Blindness—Brimonidine—glaucoma	0.0102	0.0222	CcSEcCtD
Gallium nitrate—Hypothermia—Brimonidine—glaucoma	0.0101	0.0219	CcSEcCtD
Gallium nitrate—Body temperature decreased—Brimonidine—glaucoma	0.0101	0.0219	CcSEcCtD
Gallium nitrate—IL1B—eye—glaucoma	0.00988	0.0954	CbGeAlD
Gallium nitrate—IL1B—connective tissue—glaucoma	0.00952	0.0919	CbGeAlD
Gallium nitrate—Hypothermia—Pilocarpine—glaucoma	0.00912	0.0198	CcSEcCtD
Gallium nitrate—Body temperature decreased—Pilocarpine—glaucoma	0.00912	0.0198	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—BECN1—glaucoma	0.00901	0.0207	CbGpPWpGaD
Gallium nitrate—TF—eye—glaucoma	0.00881	0.0851	CbGeAlD
Gallium nitrate—TF—retina—glaucoma	0.00874	0.0843	CbGeAlD
Gallium nitrate—ATP6V1B2—Signaling by Insulin receptor—RPTOR—glaucoma	0.00852	0.0196	CbGpPWpGaD
Gallium nitrate—TF—connective tissue—glaucoma	0.00849	0.082	CbGeAlD
Gallium nitrate—TF—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00846	0.0194	CbGpPWpGaD
Gallium nitrate—IL1B—Monoamine Transport—SLC6A1—glaucoma	0.00769	0.0177	CbGpPWpGaD
Gallium nitrate—Rales—Timolol—glaucoma	0.00708	0.0154	CcSEcCtD
Gallium nitrate—Erythema—Echothiophate—glaucoma	0.00663	0.0144	CcSEcCtD
Gallium nitrate—Lethargy—Levobunolol—glaucoma	0.0066	0.0143	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.00656	0.0151	CbGpPWpGaD
Gallium nitrate—Tachycardia—Dipivefrin—glaucoma	0.0063	0.0137	CcSEcCtD
Gallium nitrate—ATP6V1B2—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—glaucoma	0.00589	0.0135	CbGpPWpGaD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—TGFB2—glaucoma	0.00562	0.0129	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—PEX19—glaucoma	0.00522	0.012	CbGpPWpGaD
Gallium nitrate—Coma—Brimonidine—glaucoma	0.00518	0.0112	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—glaucoma	0.00516	0.0119	CbGpPWpGaD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—IL1A—glaucoma	0.00491	0.0113	CbGpPWpGaD
Gallium nitrate—Vomiting—Physostigmine—glaucoma	0.00483	0.0105	CcSEcCtD
Gallium nitrate—Hypersensitivity—Dipivefrin—glaucoma	0.00476	0.0103	CcSEcCtD
Gallium nitrate—Nausea—Physostigmine—glaucoma	0.00451	0.00979	CcSEcCtD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—CCND2—glaucoma	0.00449	0.0103	CbGpPWpGaD
Gallium nitrate—Tinnitus—Diclofenamide—glaucoma	0.00434	0.00941	CcSEcCtD
Gallium nitrate—RRM2—Nucleotide metabolism—TXN—glaucoma	0.00431	0.00989	CbGpPWpGaD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TBK1—glaucoma	0.00423	0.00972	CbGpPWpGaD
Gallium nitrate—Lethargy—Brimonidine—glaucoma	0.0042	0.00911	CcSEcCtD
Gallium nitrate—IL1B—IL1-mediated signaling events—IL1A—glaucoma	0.00408	0.00938	CbGpPWpGaD
Gallium nitrate—Tinnitus—Methazolamide—glaucoma	0.00399	0.00867	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—glaucoma	0.00399	0.00917	CbGpPWpGaD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00399	0.00916	CbGpPWpGaD
Gallium nitrate—TF—Platelet degranulation—TGFB2—glaucoma	0.00388	0.00892	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—TXN—glaucoma	0.00384	0.00882	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NTF4—glaucoma	0.00382	0.00878	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—glaucoma	0.00374	0.00859	CbGpPWpGaD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—MTHFR—glaucoma	0.00374	0.00859	CbGpPWpGaD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.0037	0.0085	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—ABCA1—glaucoma	0.00367	0.00843	CbGpPWpGaD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—glaucoma	0.00366	0.0084	CbGpPWpGaD
Gallium nitrate—Leukopenia—Diclofenamide—glaucoma	0.00363	0.00787	CcSEcCtD
Gallium nitrate—Erythema—Latanoprost—glaucoma	0.00361	0.00783	CcSEcCtD
Gallium nitrate—IL1B—Hematopoietic Stem Cell Differentiation—IL1A—glaucoma	0.00358	0.00823	CbGpPWpGaD
Gallium nitrate—IL1B—Interleukin-1 signaling—IL1A—glaucoma	0.00358	0.00823	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00352	0.00809	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—C1QB—glaucoma	0.00341	0.00783	CbGpPWpGaD
Gallium nitrate—Leukopenia—Methazolamide—glaucoma	0.00334	0.00724	CcSEcCtD
Gallium nitrate—Confusional state—Diclofenamide—glaucoma	0.00333	0.00723	CcSEcCtD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TBK1—glaucoma	0.00331	0.00759	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—SOD1—glaucoma	0.00327	0.00751	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Apraclonidine—glaucoma	0.00327	0.00708	CcSEcCtD
Gallium nitrate—Dyspnoea—Metipranolol—glaucoma	0.00324	0.00702	CcSEcCtD
Gallium nitrate—Confusional state—Levobunolol—glaucoma	0.0032	0.00695	CcSEcCtD
Gallium nitrate—Oedema peripheral—Bimatoprost—glaucoma	0.00317	0.00687	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.00312	0.00715	CbGpPWpGaD
Gallium nitrate—Confusional state—Methazolamide—glaucoma	0.00307	0.00666	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00303	0.00697	CbGpPWpGaD
Gallium nitrate—Lethargy—Clonidine—glaucoma	0.00303	0.00656	CcSEcCtD
Gallium nitrate—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—glaucoma	0.003	0.00689	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Carteolol—glaucoma	0.003	0.0065	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—ABCA1—glaucoma	0.00299	0.00686	CbGpPWpGaD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—NR3C1—glaucoma	0.00297	0.00682	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Diclofenamide—glaucoma	0.00297	0.00644	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—SOD1—glaucoma	0.00294	0.00676	CbGpPWpGaD
Gallium nitrate—Erythema—Apraclonidine—glaucoma	0.00289	0.00626	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—PEX19—glaucoma	0.00286	0.00657	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Levobunolol—glaucoma	0.00285	0.00619	CcSEcCtD
Gallium nitrate—Dyspnoea—Levobunolol—glaucoma	0.00283	0.00614	CcSEcCtD
Gallium nitrate—Constipation—Diclofenamide—glaucoma	0.00283	0.00613	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.0028	0.00644	CbGpPWpGaD
Gallium nitrate—Erythema—Bimatoprost—glaucoma	0.0028	0.00607	CcSEcCtD
Gallium nitrate—IL1B—IL-1 signaling pathway—IL1A—glaucoma	0.00278	0.00638	CbGpPWpGaD
Gallium nitrate—Tinnitus—Acetazolamide—glaucoma	0.00277	0.006	CcSEcCtD
Gallium nitrate—Paraesthesia—Methazolamide—glaucoma	0.00273	0.00593	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—MMP1—glaucoma	0.00273	0.00627	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Diclofenamide—glaucoma	0.00272	0.00591	CcSEcCtD
Gallium nitrate—Hallucination—Dorzolamide—glaucoma	0.0027	0.00587	CcSEcCtD
Gallium nitrate—BGLAP—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.00268	0.00615	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Metipranolol—glaucoma	0.00267	0.0058	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—SOD1—glaucoma	0.00266	0.00611	CbGpPWpGaD
Gallium nitrate—IL1B—IL1 and megakaryotyces in obesity—MMP9—glaucoma	0.00265	0.00609	CbGpPWpGaD
Gallium nitrate—Lethargy—Betaxolol—glaucoma	0.00263	0.00571	CcSEcCtD
Gallium nitrate—Oedema peripheral—Brinzolamide—glaucoma	0.00263	0.00571	CcSEcCtD
Gallium nitrate—Dyspnoea—Latanoprost—glaucoma	0.00263	0.0057	CcSEcCtD
Gallium nitrate—Feeling abnormal—Levobunolol—glaucoma	0.00262	0.00568	CcSEcCtD
Gallium nitrate—Body temperature increased—Diclofenamide—glaucoma	0.00261	0.00567	CcSEcCtD
Gallium nitrate—ATP6V1B2—Disease—LRP12—glaucoma	0.0026	0.00597	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—MTHFR—glaucoma	0.00259	0.00596	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Carbachol—glaucoma	0.00255	0.00553	CcSEcCtD
Gallium nitrate—Tinnitus—Dorzolamide—glaucoma	0.00253	0.0055	CcSEcCtD
Gallium nitrate—Oedema peripheral—Pilocarpine—glaucoma	0.00253	0.00549	CcSEcCtD
Gallium nitrate—Tinnitus—Travoprost—glaucoma	0.00252	0.00547	CcSEcCtD
Gallium nitrate—Feeling abnormal—Methazolamide—glaucoma	0.00251	0.00544	CcSEcCtD
Gallium nitrate—Tinnitus—Brinzolamide—glaucoma	0.00249	0.00541	CcSEcCtD
Gallium nitrate—Erythema—Brimonidine—glaucoma	0.00248	0.00537	CcSEcCtD
Gallium nitrate—Hypersensitivity—Carteolol—glaucoma	0.00248	0.00537	CcSEcCtD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—APOE—glaucoma	0.00241	0.00555	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Methazolamide—glaucoma	0.00241	0.00522	CcSEcCtD
Gallium nitrate—Tinnitus—Pilocarpine—glaucoma	0.00239	0.0052	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—ABCA1—glaucoma	0.00237	0.00545	CbGpPWpGaD
Gallium nitrate—Erythema—Dorzolamide—glaucoma	0.00237	0.00513	CcSEcCtD
Gallium nitrate—Erythema—Travoprost—glaucoma	0.00236	0.00511	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00235	0.0054	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00235	0.0054	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Levobunolol—glaucoma	0.00234	0.00508	CcSEcCtD
Gallium nitrate—Pruritus—Diclofenamide—glaucoma	0.00234	0.00507	CcSEcCtD
Gallium nitrate—Erythema—Brinzolamide—glaucoma	0.00233	0.00505	CcSEcCtD
Gallium nitrate—Leukopenia—Acetazolamide—glaucoma	0.00231	0.00501	CcSEcCtD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—CDKN2A—glaucoma	0.0023	0.00529	CbGpPWpGaD
Gallium nitrate—Rash—Metipranolol—glaucoma	0.00229	0.00496	CcSEcCtD
Gallium nitrate—Dermatitis—Metipranolol—glaucoma	0.00229	0.00496	CcSEcCtD
Gallium nitrate—Pruritus—Levobunolol—glaucoma	0.00225	0.00488	CcSEcCtD
Gallium nitrate—BGLAP—FGF signaling pathway—MMP9—glaucoma	0.00222	0.00509	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Carbachol—glaucoma	0.00221	0.00479	CcSEcCtD
Gallium nitrate—IL1B—Cellular roles of Anthrax toxin—TNF—glaucoma	0.00219	0.00503	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Levobunolol—glaucoma	0.00217	0.00472	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00217	0.00499	CbGpPWpGaD
Gallium nitrate—Nausea—Metipranolol—glaucoma	0.00216	0.00468	CcSEcCtD
Gallium nitrate—Confusional state—Acetazolamide—glaucoma	0.00212	0.00461	CcSEcCtD
Gallium nitrate—Paraesthesia—Apraclonidine—glaucoma	0.00212	0.00459	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—SOD1—glaucoma	0.00211	0.00486	CbGpPWpGaD
Gallium nitrate—IL1B—Folate Metabolism—MTHFR—glaucoma	0.00211	0.00485	CbGpPWpGaD
Gallium nitrate—Vomiting—Diclofenamide—glaucoma	0.0021	0.00456	CcSEcCtD
Gallium nitrate—Dyspnoea—Apraclonidine—glaucoma	0.0021	0.00456	CcSEcCtD
Gallium nitrate—Pruritus—Latanoprost—glaucoma	0.00208	0.00452	CcSEcCtD
Gallium nitrate—Rash—Diclofenamide—glaucoma	0.00208	0.00452	CcSEcCtD
Gallium nitrate—Diarrhoea—Methazolamide—glaucoma	0.00208	0.00452	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—IL1A—glaucoma	0.00208	0.00478	CbGpPWpGaD
Gallium nitrate—Vomiting—Carbachol—glaucoma	0.00205	0.00445	CcSEcCtD
Gallium nitrate—TF—Platelet degranulation—FN1—glaucoma	0.00205	0.0047	CbGpPWpGaD
Gallium nitrate—Hallucination—Clonidine—glaucoma	0.00204	0.00443	CcSEcCtD
Gallium nitrate—BGLAP—Regulation of retinoblastoma protein—CDKN1B—glaucoma	0.00204	0.00468	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Bimatoprost—glaucoma	0.00204	0.00442	CcSEcCtD
Gallium nitrate—Rash—Carbachol—glaucoma	0.00203	0.00441	CcSEcCtD
Gallium nitrate—Dermatitis—Carbachol—glaucoma	0.00203	0.00441	CcSEcCtD
Gallium nitrate—Constipation—Apraclonidine—glaucoma	0.00201	0.00437	CcSEcCtD
Gallium nitrate—Leukopenia—Pilocarpine—glaucoma	0.002	0.00434	CcSEcCtD
Gallium nitrate—Nausea—Carteolol—glaucoma	0.002	0.00433	CcSEcCtD
Gallium nitrate—Tachycardia—Brimonidine—glaucoma	0.00197	0.00428	CcSEcCtD
Gallium nitrate—Nausea—Diclofenamide—glaucoma	0.00196	0.00426	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.00195	0.00448	CbGpPWpGaD
Gallium nitrate—Confusional state—Dorzolamide—glaucoma	0.00195	0.00422	CcSEcCtD
Gallium nitrate—Feeling abnormal—Apraclonidine—glaucoma	0.00194	0.00421	CcSEcCtD
Gallium nitrate—Vomiting—Methazolamide—glaucoma	0.00194	0.0042	CcSEcCtD
Gallium nitrate—TF—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00193	0.00443	CbGpPWpGaD
Gallium nitrate—Rash—Methazolamide—glaucoma	0.00192	0.00416	CcSEcCtD
Gallium nitrate—Dermatitis—Methazolamide—glaucoma	0.00192	0.00416	CcSEcCtD
Gallium nitrate—Nausea—Carbachol—glaucoma	0.00192	0.00416	CcSEcCtD
Gallium nitrate—IL1B—IL27-mediated signaling events—TNF—glaucoma	0.00191	0.0044	CbGpPWpGaD
Gallium nitrate—Tinnitus—Clonidine—glaucoma	0.00191	0.00415	CcSEcCtD
Gallium nitrate—Paraesthesia—Acetazolamide—glaucoma	0.00189	0.0041	CcSEcCtD
Gallium nitrate—Nausea—Levobunolol—glaucoma	0.00189	0.00409	CcSEcCtD
Gallium nitrate—Tachycardia—Travoprost—glaucoma	0.00188	0.00407	CcSEcCtD
Gallium nitrate—IL1B—TCR Signaling Pathway—IL1A—glaucoma	0.00187	0.0043	CbGpPWpGaD
Gallium nitrate—Rash—Latanoprost—glaucoma	0.00186	0.00403	CcSEcCtD
Gallium nitrate—IL1B—Cytokines and Inflammatory Response—TNF—glaucoma	0.00186	0.00427	CbGpPWpGaD
Gallium nitrate—Dermatitis—Latanoprost—glaucoma	0.00186	0.00403	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—FAS—glaucoma	0.00185	0.00426	CbGpPWpGaD
Gallium nitrate—IL1B—Allograft Rejection—FAS—glaucoma	0.00185	0.00426	CbGpPWpGaD
Gallium nitrate—Tachycardia—Brinzolamide—glaucoma	0.00185	0.00402	CcSEcCtD
Gallium nitrate—Confusional state—Pilocarpine—glaucoma	0.00184	0.00399	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—C3—glaucoma	0.00183	0.0042	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—BCL2L1—glaucoma	0.00182	0.00419	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—LRP12—glaucoma	0.00182	0.00418	CbGpPWpGaD
Gallium nitrate—Paraesthesia—Brimonidine—glaucoma	0.00182	0.00394	CcSEcCtD
Gallium nitrate—Nausea—Methazolamide—glaucoma	0.00181	0.00392	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—NGFR—glaucoma	0.00181	0.00415	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Brimonidine—glaucoma	0.0018	0.00391	CcSEcCtD
Gallium nitrate—Erythema—Clonidine—glaucoma	0.00179	0.00387	CcSEcCtD
Gallium nitrate—Tachycardia—Pilocarpine—glaucoma	0.00178	0.00386	CcSEcCtD
Gallium nitrate—Hallucination—Betaxolol—glaucoma	0.00178	0.00385	CcSEcCtD
Gallium nitrate—TF—Differentiation Pathway—VEGFA—glaucoma	0.00176	0.00405	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Acetazolamide—glaucoma	0.00174	0.00377	CcSEcCtD
Gallium nitrate—Hypersensitivity—Apraclonidine—glaucoma	0.00174	0.00376	CcSEcCtD
Gallium nitrate—Paraesthesia—Dorzolamide—glaucoma	0.00173	0.00376	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.00172	0.00396	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Dorzolamide—glaucoma	0.00172	0.00374	CcSEcCtD
Gallium nitrate—ATP6V1B2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00172	0.00395	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Travoprost—glaucoma	0.00171	0.00372	CcSEcCtD
Gallium nitrate—Paraesthesia—Brinzolamide—glaucoma	0.0017	0.0037	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.0017	0.00391	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—APOE—glaucoma	0.0017	0.00391	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Brinzolamide—glaucoma	0.00169	0.00367	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00168	0.00387	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—MTHFR—glaucoma	0.00168	0.00385	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—FGFR1OP—glaucoma	0.00168	0.00385	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HEYL—glaucoma	0.00168	0.00385	CbGpPWpGaD
Gallium nitrate—IL1B—TCR Signaling Pathway—FAS—glaucoma	0.00167	0.00384	CbGpPWpGaD
Gallium nitrate—Pruritus—Apraclonidine—glaucoma	0.00167	0.00362	CcSEcCtD
Gallium nitrate—Body temperature increased—Acetazolamide—glaucoma	0.00167	0.00361	CcSEcCtD
Gallium nitrate—Tinnitus—Betaxolol—glaucoma	0.00167	0.00361	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TGFB2—glaucoma	0.00166	0.00382	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—IL1A—glaucoma	0.00166	0.0038	CbGpPWpGaD
Gallium nitrate—IL1B—Leptin signaling pathway—BAD—glaucoma	0.00165	0.0038	CbGpPWpGaD
Gallium nitrate—Constipation—Travoprost—glaucoma	0.00164	0.00357	CcSEcCtD
Gallium nitrate—Paraesthesia—Pilocarpine—glaucoma	0.00164	0.00355	CcSEcCtD
Gallium nitrate—Dyspnoea—Pilocarpine—glaucoma	0.00163	0.00353	CcSEcCtD
Gallium nitrate—IL1B—Monoamine Transport—TNF—glaucoma	0.00162	0.00372	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00162	0.00372	CbGpPWpGaD
Gallium nitrate—IL1B—Signaling by Interleukins—IL1A—glaucoma	0.00162	0.00372	CbGpPWpGaD
Gallium nitrate—Pruritus—Bimatoprost—glaucoma	0.00162	0.00351	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CCND2—glaucoma	0.00161	0.0037	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Apraclonidine—glaucoma	0.00161	0.0035	CcSEcCtD
Gallium nitrate—Feeling abnormal—Dorzolamide—glaucoma	0.00159	0.00345	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—BAD—glaucoma	0.00159	0.00364	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Travoprost—glaucoma	0.00158	0.00344	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—FGFR1OP—glaucoma	0.00158	0.00363	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—BDNF—glaucoma	0.00157	0.00361	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Brinzolamide—glaucoma	0.00156	0.00339	CcSEcCtD
Gallium nitrate—Constipation—Pilocarpine—glaucoma	0.00156	0.00339	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00156	0.00357	CbGpPWpGaD
Gallium nitrate—Erythema—Betaxolol—glaucoma	0.00155	0.00337	CcSEcCtD
Gallium nitrate—Body temperature increased—Dorzolamide—glaucoma	0.00153	0.00331	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—IL1A—glaucoma	0.00151	0.00347	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Pilocarpine—glaucoma	0.0015	0.00326	CcSEcCtD
Gallium nitrate—Vomiting—Apraclonidine—glaucoma	0.0015	0.00325	CcSEcCtD
Gallium nitrate—Hypersensitivity—Brimonidine—glaucoma	0.00149	0.00323	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—RAB8A—glaucoma	0.00149	0.00341	CbGpPWpGaD
Gallium nitrate—Dermatitis—Apraclonidine—glaucoma	0.00148	0.00322	CcSEcCtD
Gallium nitrate—Confusional state—Clonidine—glaucoma	0.00147	0.00319	CcSEcCtD
Gallium nitrate—Hallucination—Timolol—glaucoma	0.00145	0.00315	CcSEcCtD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.00145	0.00332	CbGpPWpGaD
Gallium nitrate—IL1B—IL23-mediated signaling events—TNF—glaucoma	0.00144	0.00332	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Pilocarpine—glaucoma	0.00144	0.00313	CcSEcCtD
Gallium nitrate—Diarrhoea—Acetazolamide—glaucoma	0.00144	0.00313	CcSEcCtD
Gallium nitrate—Rash—Bimatoprost—glaucoma	0.00144	0.00312	CcSEcCtD
Gallium nitrate—Dermatitis—Bimatoprost—glaucoma	0.00144	0.00312	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—NGF—glaucoma	0.00144	0.0033	CbGpPWpGaD
Gallium nitrate—Oedema peripheral—Timolol—glaucoma	0.00144	0.00312	CcSEcCtD
Gallium nitrate—Anaemia—Betaxolol—glaucoma	0.00144	0.00312	CcSEcCtD
Gallium nitrate—TF—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00143	0.00329	CbGpPWpGaD
Gallium nitrate—Pruritus—Brimonidine—glaucoma	0.00143	0.0031	CcSEcCtD
Gallium nitrate—Hypersensitivity—Dorzolamide—glaucoma	0.00142	0.00309	CcSEcCtD
Gallium nitrate—Tachycardia—Clonidine—glaucoma	0.00142	0.00309	CcSEcCtD
Gallium nitrate—RRM2—Fluoropyrimidine Activity—TP53—glaucoma	0.00142	0.00326	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Travoprost—glaucoma	0.00142	0.00307	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—FGFR1OP—glaucoma	0.00141	0.00325	CbGpPWpGaD
Gallium nitrate—Nausea—Apraclonidine—glaucoma	0.0014	0.00304	CcSEcCtD
Gallium nitrate—Hypersensitivity—Brinzolamide—glaucoma	0.0014	0.00303	CcSEcCtD
Gallium nitrate—TF—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.00137	0.00314	CbGpPWpGaD
Gallium nitrate—Pruritus—Dorzolamide—glaucoma	0.00137	0.00296	CcSEcCtD
Gallium nitrate—Pruritus—Travoprost—glaucoma	0.00136	0.00295	CcSEcCtD
Gallium nitrate—Tinnitus—Timolol—glaucoma	0.00136	0.00295	CcSEcCtD
Gallium nitrate—Nausea—Bimatoprost—glaucoma	0.00136	0.00294	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—CDKN2A—glaucoma	0.00135	0.00311	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Pilocarpine—glaucoma	0.00134	0.00292	CcSEcCtD
Gallium nitrate—Pruritus—Brinzolamide—glaucoma	0.00134	0.00291	CcSEcCtD
Gallium nitrate—Vomiting—Acetazolamide—glaucoma	0.00134	0.00291	CcSEcCtD
Gallium nitrate—IL1B—Leptin signaling pathway—NOS3—glaucoma	0.00133	0.00305	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—RAB8A—glaucoma	0.00133	0.00305	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Dorzolamide—glaucoma	0.00132	0.00287	CcSEcCtD
Gallium nitrate—Diarrhoea—Travoprost—glaucoma	0.00132	0.00285	CcSEcCtD
Gallium nitrate—Paraesthesia—Clonidine—glaucoma	0.00131	0.00284	CcSEcCtD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.00131	0.003	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Clonidine—glaucoma	0.0013	0.00282	CcSEcCtD
Gallium nitrate—Diarrhoea—Brinzolamide—glaucoma	0.0013	0.00282	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NTRK1—glaucoma	0.00129	0.00297	CbGpPWpGaD
Gallium nitrate—Pruritus—Pilocarpine—glaucoma	0.00129	0.0028	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—OPTN—glaucoma	0.00129	0.00296	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00129	0.00296	CbGpPWpGaD
Gallium nitrate—Confusional state—Betaxolol—glaucoma	0.00128	0.00278	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—FN1—glaucoma	0.00128	0.00293	CbGpPWpGaD
Gallium nitrate—Rash—Brimonidine—glaucoma	0.00128	0.00277	CcSEcCtD
Gallium nitrate—Dermatitis—Brimonidine—glaucoma	0.00127	0.00276	CcSEcCtD
Gallium nitrate—Erythema—Timolol—glaucoma	0.00127	0.00275	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—OPN4—glaucoma	0.00126	0.0029	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00126	0.00289	CbGpPWpGaD
Gallium nitrate—Nausea—Acetazolamide—glaucoma	0.00125	0.00271	CcSEcCtD
Gallium nitrate—Diarrhoea—Pilocarpine—glaucoma	0.00125	0.00271	CcSEcCtD
Gallium nitrate—Constipation—Clonidine—glaucoma	0.00125	0.0027	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—NARFL—glaucoma	0.00124	0.00286	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CA5A—glaucoma	0.00124	0.00286	CbGpPWpGaD
Gallium nitrate—Tachycardia—Betaxolol—glaucoma	0.00124	0.00269	CcSEcCtD
Gallium nitrate—Vomiting—Dorzolamide—glaucoma	0.00123	0.00266	CcSEcCtD
Gallium nitrate—Rash—Dorzolamide—glaucoma	0.00122	0.00264	CcSEcCtD
Gallium nitrate—Dermatitis—Dorzolamide—glaucoma	0.00122	0.00264	CcSEcCtD
Gallium nitrate—IL1B—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.00121	0.00279	CbGpPWpGaD
Gallium nitrate—Rash—Travoprost—glaucoma	0.00121	0.00263	CcSEcCtD
Gallium nitrate—Dermatitis—Travoprost—glaucoma	0.00121	0.00263	CcSEcCtD
Gallium nitrate—Vomiting—Brinzolamide—glaucoma	0.00121	0.00262	CcSEcCtD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00121	0.00277	CbGpPWpGaD
Gallium nitrate—Nausea—Brimonidine—glaucoma	0.0012	0.00261	CcSEcCtD
Gallium nitrate—Feeling abnormal—Clonidine—glaucoma	0.0012	0.00261	CcSEcCtD
Gallium nitrate—RRM2—E2F transcription factor network—CDKN1B—glaucoma	0.0012	0.00275	CbGpPWpGaD
Gallium nitrate—Rash—Brinzolamide—glaucoma	0.0012	0.0026	CcSEcCtD
Gallium nitrate—Dermatitis—Brinzolamide—glaucoma	0.0012	0.00259	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—BDNF—glaucoma	0.00118	0.00272	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HEYL—glaucoma	0.00117	0.0027	CbGpPWpGaD
Gallium nitrate—TF—Platelet degranulation—VEGFA—glaucoma	0.00117	0.00269	CbGpPWpGaD
Gallium nitrate—Vomiting—Pilocarpine—glaucoma	0.00116	0.00252	CcSEcCtD
Gallium nitrate—Body temperature increased—Clonidine—glaucoma	0.00115	0.0025	CcSEcCtD
Gallium nitrate—RRM2—Cell Cycle—OPTN—glaucoma	0.00115	0.00265	CbGpPWpGaD
Gallium nitrate—Rash—Pilocarpine—glaucoma	0.00115	0.0025	CcSEcCtD
Gallium nitrate—Dermatitis—Pilocarpine—glaucoma	0.00115	0.00249	CcSEcCtD
Gallium nitrate—Nausea—Dorzolamide—glaucoma	0.00115	0.00249	CcSEcCtD
Gallium nitrate—Nausea—Travoprost—glaucoma	0.00114	0.00248	CcSEcCtD
Gallium nitrate—Paraesthesia—Betaxolol—glaucoma	0.00114	0.00247	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—IL1A—glaucoma	0.00114	0.00261	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—PTGFR—glaucoma	0.00114	0.00261	CbGpPWpGaD
Gallium nitrate—Dyspnoea—Betaxolol—glaucoma	0.00113	0.00245	CcSEcCtD
Gallium nitrate—Nausea—Brinzolamide—glaucoma	0.00113	0.00245	CcSEcCtD
Gallium nitrate—TF—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.00112	0.00257	CbGpPWpGaD
Gallium nitrate—IL1B—Vitamin B12 Metabolism—TNF—glaucoma	0.00112	0.00257	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—NGF—glaucoma	0.00112	0.00256	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00111	0.00255	CbGpPWpGaD
Gallium nitrate—Constipation—Betaxolol—glaucoma	0.00108	0.00235	CcSEcCtD
Gallium nitrate—Nausea—Pilocarpine—glaucoma	0.00108	0.00235	CcSEcCtD
Gallium nitrate—BGLAP—Glucocorticoid receptor regulatory network—TP53—glaucoma	0.00108	0.00247	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Clonidine—glaucoma	0.00107	0.00233	CcSEcCtD
Gallium nitrate—IL1B—Selenium Micronutrient Network—PTGS2—glaucoma	0.00107	0.00246	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—NGF—glaucoma	0.00105	0.00241	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—HDAC9—glaucoma	0.00105	0.0024	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Betaxolol—glaucoma	0.00105	0.00227	CcSEcCtD
Gallium nitrate—Confusional state—Timolol—glaucoma	0.00105	0.00227	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.00104	0.00239	CbGpPWpGaD
Gallium nitrate—Pruritus—Clonidine—glaucoma	0.00103	0.00224	CcSEcCtD
Gallium nitrate—IL1B—MAPK Signaling Pathway—FAS—glaucoma	0.00101	0.00233	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Betaxolol—glaucoma	0.001	0.00218	CcSEcCtD
Gallium nitrate—Diarrhoea—Clonidine—glaucoma	0.000997	0.00216	CcSEcCtD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN2A—glaucoma	0.000993	0.00228	CbGpPWpGaD
Gallium nitrate—TF—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000943	0.00217	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Betaxolol—glaucoma	0.000935	0.00203	CcSEcCtD
Gallium nitrate—Paraesthesia—Timolol—glaucoma	0.000931	0.00202	CcSEcCtD
Gallium nitrate—Vomiting—Clonidine—glaucoma	0.000927	0.00201	CcSEcCtD
Gallium nitrate—Dyspnoea—Timolol—glaucoma	0.000924	0.002	CcSEcCtD
Gallium nitrate—Rash—Clonidine—glaucoma	0.000919	0.00199	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—VEGFA—glaucoma	0.000918	0.00211	CbGpPWpGaD
Gallium nitrate—Dermatitis—Clonidine—glaucoma	0.000918	0.00199	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—TNF—glaucoma	0.000909	0.00209	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000909	0.00209	CbGpPWpGaD
Gallium nitrate—Pruritus—Betaxolol—glaucoma	0.000898	0.00195	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—RPTOR—glaucoma	0.000889	0.00204	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TGFB2—glaucoma	0.000888	0.00204	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—CDKN1B—glaucoma	0.000879	0.00202	CbGpPWpGaD
Gallium nitrate—RRM2—G1/S Transition—CDKN1B—glaucoma	0.000869	0.002	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Betaxolol—glaucoma	0.000868	0.00188	CcSEcCtD
Gallium nitrate—Nausea—Clonidine—glaucoma	0.000866	0.00188	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NCK2—glaucoma	0.000861	0.00198	CbGpPWpGaD
Gallium nitrate—Feeling abnormal—Timolol—glaucoma	0.000854	0.00185	CcSEcCtD
Gallium nitrate—IL1B—Spinal Cord Injury—PTGS2—glaucoma	0.000846	0.00194	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000827	0.0019	CbGpPWpGaD
Gallium nitrate—Body temperature increased—Timolol—glaucoma	0.000819	0.00178	CcSEcCtD
Gallium nitrate—Vomiting—Betaxolol—glaucoma	0.000807	0.00175	CcSEcCtD
Gallium nitrate—IL1B—Folate Metabolism—TP53—glaucoma	0.000801	0.00184	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—CDKN1B—glaucoma	0.000801	0.00184	CbGpPWpGaD
Gallium nitrate—Rash—Betaxolol—glaucoma	0.0008	0.00174	CcSEcCtD
Gallium nitrate—Dermatitis—Betaxolol—glaucoma	0.000799	0.00173	CcSEcCtD
Gallium nitrate—IL1B—Allograft Rejection—TNF—glaucoma	0.000787	0.00181	CbGpPWpGaD
Gallium nitrate—IL1B—Alzheimers Disease—TNF—glaucoma	0.000787	0.00181	CbGpPWpGaD
Gallium nitrate—Hypersensitivity—Timolol—glaucoma	0.000764	0.00166	CcSEcCtD
Gallium nitrate—IL1B—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000756	0.00174	CbGpPWpGaD
Gallium nitrate—Nausea—Betaxolol—glaucoma	0.000754	0.00163	CcSEcCtD
Gallium nitrate—IL1B—Immune System—CTSA—glaucoma	0.000747	0.00172	CbGpPWpGaD
Gallium nitrate—IL1B—Myometrial Relaxation and Contraction Pathways—NOS3—glaucoma	0.000743	0.00171	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—MMP9—glaucoma	0.000742	0.0017	CbGpPWpGaD
Gallium nitrate—Pruritus—Timolol—glaucoma	0.000733	0.00159	CcSEcCtD
Gallium nitrate—ATP6V1B2—Signaling Pathways—HDAC9—glaucoma	0.000732	0.00168	CbGpPWpGaD
Gallium nitrate—RRM2—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000732	0.00168	CbGpPWpGaD
Gallium nitrate—IL1B—Selenium Micronutrient Network—TNF—glaucoma	0.000722	0.00166	CbGpPWpGaD
Gallium nitrate—Diarrhoea—Timolol—glaucoma	0.000709	0.00154	CcSEcCtD
Gallium nitrate—IL1B—Alzheimers Disease—TP53—glaucoma	0.000694	0.00159	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000687	0.00158	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—SOD1—glaucoma	0.000673	0.00155	CbGpPWpGaD
Gallium nitrate—Vomiting—Timolol—glaucoma	0.000659	0.00143	CcSEcCtD
Gallium nitrate—RRM2—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000654	0.0015	CbGpPWpGaD
Gallium nitrate—Rash—Timolol—glaucoma	0.000654	0.00142	CcSEcCtD
Gallium nitrate—Dermatitis—Timolol—glaucoma	0.000653	0.00142	CcSEcCtD
Gallium nitrate—IL1B—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000641	0.00147	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TXNIP—glaucoma	0.000629	0.00144	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TBK1—glaucoma	0.000616	0.00142	CbGpPWpGaD
Gallium nitrate—Nausea—Timolol—glaucoma	0.000616	0.00134	CcSEcCtD
Gallium nitrate—RRM2—Metabolism—CA1—glaucoma	0.000607	0.00139	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CCND2—glaucoma	0.000592	0.00136	CbGpPWpGaD
Gallium nitrate—TF—SIDS Susceptibility Pathways—TNF—glaucoma	0.000589	0.00135	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CTSA—glaucoma	0.000588	0.00135	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—SMO—glaucoma	0.000573	0.00132	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TNF—glaucoma	0.000571	0.00131	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CDKN2B—glaucoma	0.000562	0.00129	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—C1QB—glaucoma	0.000558	0.00128	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CA2—glaucoma	0.000555	0.00128	CbGpPWpGaD
Gallium nitrate—IL1B—Senescence and Autophagy in Cancer—TP53—glaucoma	0.000553	0.00127	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000533	0.00122	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.00053	0.00122	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CCND2—glaucoma	0.000529	0.00121	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NTRK2—glaucoma	0.000524	0.0012	CbGpPWpGaD
Gallium nitrate—TF—Platelet activation, signaling and aggregation—VEGFA—glaucoma	0.00052	0.00119	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—MMP1—glaucoma	0.000513	0.00118	CbGpPWpGaD
Gallium nitrate—IL1B—Spinal Cord Injury—TP53—glaucoma	0.000503	0.00116	CbGpPWpGaD
Gallium nitrate—IL1B—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000501	0.00115	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—TXN—glaucoma	0.000497	0.00114	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—CAV1—glaucoma	0.000492	0.00113	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2B—glaucoma	0.000474	0.00109	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—MTHFR—glaucoma	0.000471	0.00108	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—FN1—glaucoma	0.000468	0.00108	CbGpPWpGaD
Gallium nitrate—IL1B—SIDS Susceptibility Pathways—TNF—glaucoma	0.000457	0.00105	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NGFR—glaucoma	0.00045	0.00103	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—APOE—glaucoma	0.000439	0.00101	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CAV1—glaucoma	0.000435	0.000999	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TNF—glaucoma	0.00043	0.000988	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NTRK1—glaucoma	0.000427	0.000981	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—BAD—glaucoma	0.000409	0.000939	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CDKN2B—glaucoma	0.000394	0.000904	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—TXN—glaucoma	0.000391	0.000899	CbGpPWpGaD
Gallium nitrate—IL1B—MAPK Signaling Pathway—TP53—glaucoma	0.000379	0.000871	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—EDN1—glaucoma	0.000378	0.000868	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—NOS3—glaucoma	0.000372	0.000855	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NGF—glaucoma	0.000347	0.000797	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—C3—glaucoma	0.00033	0.000758	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—NOS3—glaucoma	0.000329	0.000755	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—APOE—glaucoma	0.000307	0.000706	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CAV1—glaucoma	0.000304	0.000699	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTT1—glaucoma	0.000303	0.000697	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000303	0.000697	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—PTGS2—glaucoma	0.000301	0.000691	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—FN1—glaucoma	0.00029	0.000666	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—BAD—glaucoma	0.000286	0.000658	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Disease—CDKN1B—glaucoma	0.000285	0.000654	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN2A—glaucoma	0.000271	0.000623	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000269	0.000617	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—VEGFA—glaucoma	0.000268	0.000616	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—IL1A—glaucoma	0.000247	0.000567	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—ABCA1—glaucoma	0.000242	0.000555	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CYP1B1—glaucoma	0.000242	0.000555	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—CDKN1B—glaucoma	0.00024	0.000552	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—NOS3—glaucoma	0.00023	0.000529	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—C3—glaucoma	0.000217	0.000498	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—BCL2L1—glaucoma	0.000208	0.000477	CbGpPWpGaD
Gallium nitrate—TF—Hemostasis—TP53—glaucoma	0.000203	0.000465	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—CDKN1B—glaucoma	0.000199	0.000458	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—GSTM1—glaucoma	0.000193	0.000444	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—BAD—glaucoma	0.000188	0.000432	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—MMP9—glaucoma	0.000185	0.000424	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—MTHFR—glaucoma	0.000171	0.000392	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—VEGFA—glaucoma	0.000166	0.000381	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—APOE—glaucoma	0.000159	0.000365	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—CAV1—glaucoma	0.000158	0.000362	CbGpPWpGaD
Gallium nitrate—RRM2—Cell Cycle—TP53—glaucoma	0.000151	0.000347	CbGpPWpGaD
Gallium nitrate—IL1B—Immune System—CDKN1B—glaucoma	0.000131	0.000301	CbGpPWpGaD
Gallium nitrate—ATP6V1B2—Signaling Pathways—TP53—glaucoma	0.000125	0.000288	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—NOS3—glaucoma	0.000119	0.000274	CbGpPWpGaD
Gallium nitrate—RRM2—Metabolism—PTGS2—glaucoma	0.000109	0.00025	CbGpPWpGaD
